TFX Q2 2025 Earnings — Teleflex Incorporated Revenue & Financial Results | Market Cap Arena

TFXTeleflex Incorporated

$5B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$781M+4.2% YoY

Gross Profit

$431M55.2% margin

Operating Income

$155M19.9% margin

Net Income

$123M15.7% margin

EPS (Diluted)

$2.77

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

-$27M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$7.4B

Total Liabilities

$3.1B

Stockholders' Equity

$4.2B

Cash & Equivalents

$254M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$781M	$750M	+4.2%
Gross Profit	$431M	$416M	+3.5%
Operating Income	$155M	$117M	+32.9%
Net Income	$123M	$80M	+53.2%

Revenue Segments

Vascular Access

$186M26%

Interventional

$170M24%

Surgical

$114M16%

Anesthesia

$96M14%

Interventional Urology

$76M11%

Other

$60M9%

Geographic Segments

Americas Segment

$526M67%

EMEA

$166M21%

Asia

$89M11%